These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 11077077

  • 1. 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors.
    Higelin J, Py-Lang G, Paternoster C, Ellis GJ, Patel A, Dautzenberg FM.
    Neuropharmacology; 2001; 40(1):114-22. PubMed ID: 11077077
    [Abstract] [Full Text] [Related]

  • 2. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.
    Dautzenberg FM, Py-Lang G, Higelin J, Fischer C, Wright MB, Huber G.
    J Pharmacol Exp Ther; 2001 Jan; 296(1):113-20. PubMed ID: 11123370
    [Abstract] [Full Text] [Related]

  • 3. Five amino acids of the Xenopus laevis CRF (corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart.
    Dautzenberg FM, Higelin J, Brauns O, Butscha B, Hauger RL.
    Mol Pharmacol; 2002 May; 61(5):1132-9. PubMed ID: 11961131
    [Abstract] [Full Text] [Related]

  • 4. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM, Wille S.
    Regul Pept; 2004 May 15; 118(3):165-73. PubMed ID: 15003833
    [Abstract] [Full Text] [Related]

  • 5. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.
    Dautzenberg FM, Wille S, Lohmann R, Spiess J.
    Proc Natl Acad Sci U S A; 1998 Apr 28; 95(9):4941-6. PubMed ID: 9560207
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.
    Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Taché Y, Vale W.
    J Med Chem; 2002 Oct 10; 45(21):4737-47. PubMed ID: 12361401
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The highly selective CRF(2) receptor antagonist K41498 binds to presynaptic CRF(2) receptors in rat brain.
    Lawrence AJ, Krstew EV, Dautzenberg FM, Rühmann A.
    Br J Pharmacol; 2002 Jul 10; 136(6):896-904. PubMed ID: 12110614
    [Abstract] [Full Text] [Related]

  • 10. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding.
    Wille S, Sydow S, Palchaudhuri MR, Spiess J, Dautzenberg FM.
    J Neurochem; 1999 Jan 10; 72(1):388-95. PubMed ID: 9886092
    [Abstract] [Full Text] [Related]

  • 11. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH, Sutton SW, Cervini LA, Rivier JE, Vale WW.
    J Pharmacol Exp Ther; 1999 Feb 10; 288(2):729-34. PubMed ID: 9918582
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and pharmacological characterization of new highly selective CRF(2) antagonists: development of 123I-K31440 as a potential SPECT ligand.
    Rühmann A, Chapman J, Higelin J, Butscha B, Dautzenberg FM.
    Peptides; 2002 Mar 10; 23(3):453-60. PubMed ID: 11835994
    [Abstract] [Full Text] [Related]

  • 13. [¹²⁵I]YP20: a novel radioligand specific for the extracellular domain of the CRF₁ receptor.
    Gordon JC, Edwards P, Elmore CS, Lazor LA, Paschetto K, Bostwick R, Sylvester M, Mauger R, Scott C, Aharony D.
    Eur J Pharmacol; 2010 Dec 15; 649(1-3):59-63. PubMed ID: 20854803
    [Abstract] [Full Text] [Related]

  • 14. Ligand requirements of the human corticotropin-releasing factor-binding protein.
    Sutton SW, Behan DP, Lahrichi SL, Kaiser R, Corrigan A, Lowry P, Potter E, Perrin MH, Rivier J, Vale WW.
    Endocrinology; 1995 Mar 15; 136(3):1097-102. PubMed ID: 7867564
    [Abstract] [Full Text] [Related]

  • 15. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.
    Rühmann A, Bonk I, Lin CR, Rosenfeld MG, Spiess J.
    Proc Natl Acad Sci U S A; 1998 Dec 22; 95(26):15264-9. PubMed ID: 9860957
    [Abstract] [Full Text] [Related]

  • 16. Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution.
    De Souza EB.
    J Neurosci; 1987 Jan 22; 7(1):88-100. PubMed ID: 3027279
    [Abstract] [Full Text] [Related]

  • 17. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.
    Dautzenberg FM, Kilpatrick GJ, Wille S, Hauger RL.
    J Neurochem; 1999 Aug 22; 73(2):821-9. PubMed ID: 10428081
    [Abstract] [Full Text] [Related]

  • 18. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor.
    Xiong Y, Xie LY, Abou-Samra AB.
    Endocrinology; 1995 May 22; 136(5):1828-34. PubMed ID: 7720627
    [Abstract] [Full Text] [Related]

  • 19. Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay.
    Ardati A, Goetschy V, Gottowick J, Henriot S, Valdenaire O, Deuschle U, Kilpatrick GJ.
    Neuropharmacology; 1999 Mar 22; 38(3):441-8. PubMed ID: 10219982
    [Abstract] [Full Text] [Related]

  • 20. Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands.
    Hoare SR, Sullivan SK, Pahuja A, Ling N, Crowe PD, Grigoriadis DE.
    Peptides; 2003 Dec 22; 24(12):1881-97. PubMed ID: 15127940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.